Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril(R))

被引：21

作者：

Lambert, MV ^{[1
]}

Bird, JM ^{[1
]}

机构：

[1] BURDEN NEUROL HOSP,BRISTOL BS16 1QT,AVON,ENGLAND

来源：

SEIZURE | 1997年 / 6卷 / 03期

关键词：

epilepsy; obstructive sleep apnoea; vigabatrin; weight gain;

D O I：

10.1016/S1059-1311(97)80011-8

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A case of a patient with medically intractable epilepsy, who developed obstructive sleep apnoea (OSA), and an increase in seizure frequency, as a consequence of weight gain following treatment with vigabatrin is described. The relationship between exacerbation of epilepsy and sleep disruption secondary to OSA is discussed. Recommendations regarding the choice of anticonvulsants in patients at risk of developing OSA are made.

引用

收藏

页码：233 / 235

页数：3

相关论文

共 11 条

[1] ACUTE EFFECTS OF OBSTRUCTIVE SLEEP-APNEA [J].

DAVIES, RJO ;

STRADLING, JR .

BRITISH JOURNAL OF ANAESTHESIA, 1993, 71 (05) :725-729

[2] NECK CIRCUMFERENCE AND OTHER CLINICAL-FEATURES IN THE DIAGNOSIS OF THE OBSTRUCTIVE SLEEP-APNEA SYNDROME [J].

DAVIES, RJO ;

ALI, NJ ;

STRADLING, JR .

THORAX, 1992, 47 (02) :101-105

[3] EPILEPSY AND SLEEP-APNEA SYNDROME [J].

DEVINSKY, O ;

EHRENBERG, B ;

BARTHLEN, GM ;

ABRAMSON, HS ;

LUCIANO, D .

NEUROLOGY, 1994, 44 (11) :2060-2064

[4] OBSTRUCTIVE SLEEP-APNEA AND DEPRESSION - DIAGNOSTIC AND TREATMENT IMPLICATIONS [J].

KAPLAN, R .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1992, 26 (04) :586-591

[5] OBSTRUCTIVE SLEEP-APNEA [J].

MCNAMARA, SG ;

GRUNSTEIN, RR ;

SULLIVAN, CE .

THORAX, 1993, 48 (07) :754-764

[6]

REYNOLDS EH, 1992, EPILEPSIA S5, V33, P30

[7] VIGABATRIN AND PSYCHOSIS [J].

SANDER, JWAS ;

HART, YM ;

TRIMBLE, MR ;

SHORVON, SD .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (05) :435-439

[8] EVALUATION OF VIGABATRIN AS AN ADD-ON DRUG IN THE MANAGEMENT OF SEVERE EPILEPSY [J].

SANDER, JWAS ;

TREVISOLBITTENCOURT, PC ;

HART, YM ;

SHORVON, SD .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (11) :1008-1010

[9] A RISK-BENEFIT ASSESSMENT OF VIGABATRIN IN THE TREATMENT OF NEUROLOGICAL DISORDERS [J].

SRINIVASAN, J ;

RICHENS, A .

DRUG SAFETY, 1994, 10 (05) :395-405

[10] 6-YEAR FOLLOW-UP-STUDY ON THE EFFICACY AND SAFETY OF VIGABATRIN IN PATIENTS WITH EPILEPSY [J].

TARTARA, A ;

MANNI, R ;

GALIMBERTI, CA ;

MORINI, R ;

MUMFORD, JP ;

IUDICE, A ;

PERUCCA, E .

ACTA NEUROLOGICA SCANDINAVICA, 1992, 86 (03) :247-251